Asia-Pacific Neonatal Jaundice Management Market – Industry Trends and Forecast to 2028

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Medical Devices Asia Pacific Neonatal Jaundice Management Market
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Asia-Pacific Neonatal Jaundice Management Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Published Report
  • Mar 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 144
  • No of Figures: 43
Buy Now Buy Now

Asia-Pacific Neonatal Jaundice Management Market, By Management (Diagnosis, Treatment), Type (Primary Care, Secondary Care), Technology (Light-Emitting Diode Light Sources, Fluorescent, Halogen, Fiberoptic, Others), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Users, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distribution), Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific) Industry Trends and Forecast to 2028

Asia-Pacific Neonatal Jaundice Management MarketMarket Analysis and Insights: Asia-Pacific Neonatal Jaundice Management Market

The neonatal jaundice management market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.2% in the forecast period of 2021 to 2028 and is expected to reach USD 117.49 million by 2028. The rising number of neonatal jaundice patients and technological advancement for disease testing and treatment are the major drivers which propelled the demand of the neonatal jaundice management market in the forecast period. 

The term jaundice is derived from the French word ‘jaune’ which means yellow. Neonatal jaundice is characterized by the appearance of yellowish color in skin as well as eyes (sclera and conjunctiva). It is one of the most common diseases in newborns that occur in the first week of after birth. It occurs mainly in 60% of term and 80% of preterm infant.

The increase in number of preterm births especially in Asia region require extra treatment for jaundice and these babies have to stay in the hospital under the care of physician and should be monitored daily which may increase the neonatal jaundice management market growth. The less adoption of the neonatal jaundice management treatment and diagnosis especially in low-income countries may act as a restraint for the neonatal jaundice management market growth. The increasing healthcare expenditure can lead to advancement in technologies and increase in the treatment options which may act as an opportunity for the growth of the neonatal jaundice management market. The complications related with the neonatal jaundice are the challenging factor for the patient population as well as the researchers and physicians in the neonatal jaundice management market. 

The neonatal jaundice management market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Neonatal Jaundice Management MarketAsia-Pacific Neonatal Jaundice Management Market Scope and Market Size

The neonatal jaundice management market is segmented on the basis of the management, type, technology, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of management, the neonatal jaundice management market is segmented into treatment and diagnosis. In 2021, diagnosis segment is expected to dominate the neonatal jaundice management market because of rising prevalence of neonatal jaundice and neonatal jaundice diagnosis which is mandatory for every child.
  • On the basis of type, the neonatal jaundice management market is segmented into primary care and secondary care. In 2021, primary care segment is expected to dominate the neonatal jaundice management market because primary care is the common and initial criteria for the neonatal infant care suffering from jaundice.
  • On the basis of technology, the neonatal jaundice management market is segmented into fluorescent, halogen, fiberoptic, light-emitting diode light sources and others. In 2021, light-emitting diode light sources segment is expected to dominate the neonatal jaundice management market as most of the healthcare facilities have LED based products and these products are highly effective.
  • On the basis of end user, the neonatal jaundice management market is segmented into hospitals, clinics, ambulatory surgical centers, home users and others. In 2021, hospitals segment is dominating the neonatal jaundice management market because of presence of highly specialized professional and presence of well-equipped technology for the treatment of neonatal jaundice.
  • On the basis of distribution channel, the neonatal jaundice management market is segmented into direct tender, retail sales and third party distribution. In 2021, direct tender segment is expected to dominate the neonatal jaundice management market because phototherapy devices or equipment are costly which required multiple vendor analysis for the purchase of device.

Neonatal Jaundice Management Market Country Level Analysis

The neonatal jaundice management market is analyzed and market size information is provided by the country, management, type, technology, end user and distribution channel as referenced above.

The countries covered in the Asia-Pacific neonatal jaundice management market report are the Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, and Rest of Asia-Pacific.

Diagnosis segment in Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increase in prevalence of neonatal jaundice in the region. China is leading the growth of the Asia-Pacific neonatal jaundice management market and treatment segment is dominating in this country due to technological advancement for the diagnosis and treatment of jaundice.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Technological Advancement and Effective Phototherapy Treatment are boosting the Neonatal Jaundice Management Market Growth

The neonatal jaundice management market also provides you with detailed market analysis for every country growth in neonatal jaundice management industry with neonatal jaundice management drugs sales, impact of advancement in the neonatal jaundice management technology and changes in regulatory scenarios with their support for the neonatal jaundice management market. The data is available for historic period 2011 to 2019.

Competitive Landscape and Neonatal Jaundice Management Market Share Analysis

The neonatal jaundice management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to neonatal jaundice management market.

The major companies which are dealing in the Asia-Pacific neonatal jaundice management market report are Atom Medical Corp., avihealthcare, Ibis Medical, nice Neotech Medical Systems Pvt. Ltd., Phoenix Medical Systems (P) Ltd, Zhengzhou Dison Instrument And Meter Co., Ltd, Natus Medical Incorporated, Ardo, DAVID, Signify Holding, GE Healthcare (a subsidiary of General Electric Company), Drägerwerk AG & Co. KGaA , S S TECHNOMED(P)LTD, Herbert Waldmann GmbH & Co. KG, Shvabe-Zurich GmbH, GINEVRI srl among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. 

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the neonatal jaundice management market.

For instance,

  • In December 2020, Neolight had increased USD 7 million in financing for the product Skylife, Dignity Health and Honor Health Systems helped the company financially. The product was initially for the hospital purpose but now the product was for the parents who can take the product to the home and can be easily used the consumer without need of physician. This helped the company to increase the market sale of the product in coming future.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market players is enhancing the company market in the neonatal jaundice management market which also provides the benefit for organization to improve their offering for neonatal jaundice management.

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of Asia-Pacific neonatal jaundice management market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. management LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET management COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
  5. Asia-Pacific neonatal jaundice management market : Laws and regulations
  6. Market Overview
    1. Drivers
      1. Rising Patient Population Suffering from neonatal jaundice
      2. large number of risk factors
      3. rising number of NEW-BORN infants
      4. increase in preterm birth
      5. AWARENESS ABOUT NEONATAL JAUNDICE AMONG THE POPULATION
    2. restrainTs
      1. side-effects related to phototherapy
      2. product recalls
      3. limited adoption of neonatal jaundice management
    3. opportunities
      1. increasing healthcare expenditure
      2. technological advancement in diagnosis and treatment
      3. increasing disposable income
      4. increase in agreements and acquisitions
    4. challenges
      1. complications related to neonatal jaundice
      2. lack of skilled professionals
      3. diagnosis of neonatal jaundice
  7. COVID-19 IMPACT ON ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENT MARKET IN HEALTHCARE INDUSTRY
    1. PRICE IMPACT
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION FOR MANUFACTURERS / SERVICE PROVIDERS
    5. CONCLUSION
  8. Asia-Pacific neonatal jaundice management MARKET, BY Management
    1. overview
    2. Diagnosis
      1. Transcutaneous Bilirubinometer (TCB)
      2. Total Serum Bilirubin (TSB)
      3. Visual Assessment
    3. Treatment
      1. Phototherapy
        1. LED PHOTOTHERAPY
        2. FIBER-OPTIC PHOTOTHERAPY
        3. CONVENTIONAL PHOTOTHERAPY
          1. CONVENTIONAL PHOTOTHERAPY WITH COMPACT FLUORESCENT LAMP
          2. CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP
      2. Exchange Transfusion
      3. Intravenous Immunoglobulin
      4. Others
  9. asia-Pacific neonatal jaundice management MARKET, BY TYPE
    1. overview
    2. Primary CARE
    3. Secondary CARE
  10. Asia-Pacific neonatal jaundice management MARKET, BY TECHNOLOGY
    1. overview
    2. light-emitting diode light sources
    3. FIBER-OPTIC
    4. FLUORESCENT
    5. HALOGEN
  11. Asia-Pacific neonatal jaundice management MARKET, BY end user
    1. overview
    2. hospitals
    3. clinics
    4. home users
    5. ambulatory surgical centers
    6. others
  12. Asia-Pacific neonatal jaundice management MARKET, BY distribution channel
    1. overview
    2. direct tenders
    3. retail sales
    4. third party distribution
  13. Asia-Pacific neonatal jaundice management market by geography
    1. Overview
    2. ASIA-PACIFIC
      1. China
      2. Japan
      3. INDIA
      4. australia
      5. South Korea
      6. SINGAPORE
      7. Malaysia
      8. Thailand
      9. Indonesia
      10. Philippines
      11. Rest of Asia-Pacific
  14. Asia-Pacific neonatal jaundice management market : COMPANY landscape
    1. company share analysis: Asia-Pacific
  15. SWOT
  16. company profiles
    1. signify holding
      1. COMPANY SNAPSHOT
      2. REVENUE FINANCIALS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    2. ge healthcare (A Subsidiary of general electric company)
      1. COMPANY SNAPSHOT
      2. RECENT FINANCIALS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. atom medical corp.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    4. natus medical incorporated
      1. COMPANY SNAPSHOT
      2. RECENT FINANCIALS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. dragerwerk AG & Co. KGaA
      1. COMPANY SNAPSHOT
      2. RECENT FINANCIALS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    6. herbert waldmann gmbh & co. Kg
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. ardo
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    8. avihealthcare
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. david
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. GINEVRI srl
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. Ibis Medical
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. nice nanotech medical systemspvt. ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    13. phoenix medical systems (p) ltd
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. s s technomed (p) ltd
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    15. ShvabeZurich GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    16. ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  17. questionnaire
  18. related reports

List of Table

TABLE 1 REGULATION imposed by several regulatory agencies in different regions

TABLE 2 RISK FACTORS FOR NEONATAL JAUNDICE

TABLE 3 CHARACTERISTICS OF TERM AND PRETERM INFANTS

TABLE 4 HEALTHCARE EXPENDITURE IN ASIA

TABLE 5 QUESTIONNAIRE FOR THE ONLINE FOLLOW-UP

TABLE 6 TIME SCHEDULE OF ONLINE FOLLOW-UP AFTER DISCHARGE

TABLE 7 Asia-Pacific neonatal jaundice management MARKET, By management, 2019-2028 (USD Million)

TABLE 8 ASIA-PACIFIC Diagnosis in Neonatal Jaundice Management Market, By Management, 2019-2028 (USD Million)

TABLE 9 ASIA-PACIFIC TREATMENT IN NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 10 ASIA-PACIFIC TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, By management, 2019-2028 (USD Million)

TABLE 11 ASIA-PACIFIC treatment by Conventional phototherapy in Neonatal Jaundice Management Market, By management, 2019-2028 (USD Million)

TABLE 12 ASIA-PACIFIC treatment by Conventional phototherapy with Fluorescent Lamp in Neonatal Jaundice Management Market, By management, 2019-2028 (USD Million)

TABLE 13 Asia-Pacific neonatal jaundice management MARKET, By TYPE, 2019-2028 (USD Million)

TABLE 14 Asia-Pacific neonatal jaundice management MARKET, By Technology, 2019-2028 (USD Million)

TABLE 15 Asia-Pacific neonatal jaundice management MARKET, By End User, 2019-2028 (USD Million)

TABLE 16 Asia-Pacific neonatal jaundice management MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 17 ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENT MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 18 Asia-Pacific NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 19 Asia-Pacific diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)

TABLE 20 Asia-Pacific treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 21 Asia-Pacific treatment By Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 22 Asia-Pacific treatment by Conventional Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 23 Asia-Pacific Treatment by Conventional Phototherapy with Fluorescent Lamp in neonatal jaundice management Market, By Type, 2019-2028 (USD Million)

TABLE 24 Asia-Pacific neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 25 Asia-Pacific neonatal jaundice MANAGEMENT MARKET, By Technology, 2019-2028 (USD Million)

TABLE 26 Asia-Pacific NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)

TABLE 27 Asia-Pacific NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)

TABLE 28 CHINA NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 29 CHINA diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)

TABLE 30 CHINA treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 31 CHINA treatment By Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 32 CHINA treatment by Conventional Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 33 CHINA Treatment by Conventional Phototherapy with Fluorescent Lamp in neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 34 CHINA neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 35 CHINA neonatal jaundice MANAGEMENT MARKET, By Technology, 2019-2028 (USD Million)

TABLE 36 CHINA NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)

TABLE 37 CHINA NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)

TABLE 38 JAPAN NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 39 JAPAN diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)

TABLE 40 JAPAN treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 41 JAPAN treatment By Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 42 JAPAN treatment by Conventional Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 43 JAPAN Treatment by Conventional Phototherapy with Fluorescent Lamp in neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 44 JAPAN neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 45 JAPAN neonatal jaundice MANAGEMENT MARKET, By Technology, 2019-2028 (USD Million)

TABLE 46 JAPAN NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)

TABLE 47 JAPAN NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)

TABLE 48 INDIA NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 49 INDIA diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)

TABLE 50 INDIA treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 51 INDIA treatment By Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 52 INDIA treatment by Conventional Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 53 INDIA Treatment by Conventional Phototherapy with Fluorescent Lamp in neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 54 INDIA neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 55 INDIA neonatal jaundice MANAGEMENT MARKET, By Technology, 2019-2028 (USD Million)

TABLE 56 INDIA NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)

TABLE 57 INDIA NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)

TABLE 58 AUSTRALIA NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 59 AUSTRALIA diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)

TABLE 60 AUSTRALIA treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 61 AUSTRALIA treatment By Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 62 AUSTRALIA treatment by Conventional Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 63 AUSTRALIA Treatment by Conventional Phototherapy with Fluorescent Lamp in neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 64 AUSTRALIA neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 65 AUSTRALIA neonatal jaundice MANAGEMENT MARKET, By Technology, 2019-2028 (USD Million)

TABLE 66 AUSTRALIA NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)

TABLE 67 AUSTRALIA NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)

TABLE 68 SOUTH KOREA NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 69 SOUTH KOREA diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)

TABLE 70 SOUTH KOREA treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 71 SOUTH KOREA treatment By Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 72 SOUTH KOREA treatment by Conventional Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 73 SOUTH KOREA Treatment by Conventional Phototherapy with Fluorescent Lamp in neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 74 SOUTH KOREA neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 75 SOUTH KOREA neonatal jaundice MANAGEMENT MARKET, By Technology, 2019-2028 (USD Million)

TABLE 76 SOUTH KOREA NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)

TABLE 77 SOUTH KOREA NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)

TABLE 78 SINGAPORE NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 79 SINGAPORE diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)

TABLE 80 SINGAPORE treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 81 SINGAPORE treatment By Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 82 SINGAPORE treatment by Conventional Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 83 SINGAPORE Treatment by Conventional Phototherapy with Fluorescent Lamp in neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 84 SINGAPORE neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 85 SINGAPORE neonatal jaundice MANAGEMENT MARKET, By Technology, 2019-2028 (USD Million)

TABLE 86 SINGAPORE NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)

TABLE 87 SINGAPORE NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)

TABLE 88 MALAYSIA NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 89 MALAYSIA diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)

TABLE 90 MALAYSIA treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 91 MALAYSIA treatment By Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 92 MALAYSIA treatment by Conventional Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 93 MALAYSIA Treatment by Conventional Phototherapy with Fluorescent Lamp in neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 94 MALAYSIA neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 95 MALAYSIA neonatal jaundice MANAGEMENT MARKET, By Technology, 2019-2028 (USD Million)

TABLE 96 MALAYSIA NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)

TABLE 97 MALAYSIA NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)

TABLE 98 THAILAND NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 99 THAILAND diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)

TABLE 100 THAILAND treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 101 THAILAND treatment By Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 102 THAILAND treatment by Conventional Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 103 THAILAND Treatment by Conventional Phototherapy with Fluorescent Lamp in neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 104 THAILAND neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 105 THAILAND neonatal jaundice MANAGEMENT MARKET, By Technology, 2019-2028 (USD Million)

TABLE 106 THAILAND NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)

TABLE 107 THAILAND NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)

TABLE 108 INDONESIA NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 109 INDONESIA diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)

TABLE 110 INDONESIA treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 111 INDONESIA treatment By Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 112 INDONESIA treatment by Conventional Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 113 INDONESIA Treatment by Conventional Phototherapy with Fluorescent Lamp in neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 114 INDONESIA neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 115 INDONESIA neonatal jaundice MANAGEMENT MARKET, By Technology, 2019-2028 (USD Million)

TABLE 116 INDONESIA NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)

TABLE 117 INDONESIA NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)

TABLE 118 PHILIPPINES NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 119 PHILIPPINES diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)

TABLE 120 PHILIPPINES treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 121 PHILIPPINES treatment By Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 122 PHILIPPINES treatment by Conventional Phototherapy in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)

TABLE 123 PHILIPPINES Treatment by Conventional Phototherapy with Fluorescent Lamp in neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 124 PHILIPPINES neonatal jaundice MANAGEMENT MARKET, By Type, 2019-2028 (USD Million)

TABLE 125 PHILIPPINES neonatal jaundice MANAGEMENT MARKET, By Technology, 2019-2028 (USD Million)

TABLE 126 PHILIPPINES NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)

TABLE 127 PHILIPPINES NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)

TABLE 128 rest of Asia-Pacific NEONATAL JAUNDICE MANAGEMENT Market, By type, 2019-2028 (USD Million)

List of Figure

FIGURE 1 Asia-Pacific neonatal jaundice management market : SEGMENTATION

FIGURE 2 ASIA-PACIFIC NEONATAL JAUNDICE MANAGEMENT MARKET : DATA TRIANGULATION

FIGURE 3 Asia-Pacific neonatal jaundice management market : DROC ANALYSIS

FIGURE 4 Asia-Pacific neonatal jaundice managementMARKET: REGIONAL VS. COUNTRY MARKET ANALYSIS

FIGURE 5 Asia-Pacific neonatal jaundice management market : COMPANY RESEARCH ANALYSIS

FIGURE 6 Asia-Pacific neonatal jaundice management market : MULTIVARIATE MODELLING

FIGURE 7 Asia-Pacific neonatal jaundice management market : INTERVIEW DEMOGRAPHICS

FIGURE 8 Asia-Pacific neonatal jaundice management market : DBMR MARKET POSITION GRID

FIGURE 9 Asia-Pacific neonatal jaundice management market : VENDOR SHARE ANALYSIS

FIGURE 10 Asia-Pacific neonatal jaundice management market : MARKET management COVERAGE GRID

FIGURE 11 ASIA-PACIFIC Bronchiectasis market: SEGMENTATION

FIGURE 12 RISING PATIENT POPULATION SUFFERING FROM neonatal jaundice is DRIVing THE Asia-Pacific neonatal jaundice management market iN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 Management SEGMENT is expected to account for the largest share of the Asia-Pacific neonatal jaundice management market in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF Asia-Pacific neonatal jaundice management market

FIGURE 15 GRAPHICAL REPRESENTATION FOR NUMBER OF PRETERM CHILDBIRTH FOR DIFFERENT COUNTRIES

FIGURE 16 Asia-Pacific neonatal jaundice management MARKET: BY management, 2020

FIGURE 17 Asia-Pacific neonatal jaundice management MARKET: BY management, 2021-2028 (USD Million)

FIGURE 18 Asia-Pacific neonatal jaundice management MARKET: BY management, CAGR (2021-2028)

FIGURE 19 Asia-Pacific neonatal jaundice management MARKET: BY management, LIFELINE CURVE

FIGURE 20 Asia-Pacific neonatal jaundice management MARKET: BY Type, 2020

FIGURE 21 Asia-Pacific neonatal jaundice management MARKET: BY type, 2021-2028 (USD Million)

FIGURE 22 Asia-Pacific neonatal jaundice management MARKET: BY type, CAGR (2021-2028)

FIGURE 23 Asia-Pacific neonatal jaundice management MARKET: BY type, LIFELINE CURVE

FIGURE 24 Asia-Pacific neonatal jaundice management MARKET: BY Technology, 2020

FIGURE 25 Asia-Pacific neonatal jaundice management MARKET: BY Technology, 2021-2028 (USD Million)

FIGURE 26 Asia-Pacific neonatal jaundice management MARKET: BY Technology, CAGR (2021-2028)

FIGURE 27 Asia-Pacific neonatal jaundice management MARKET: BY Technology, LIFELINE CURVE

FIGURE 28 Asia-Pacific neonatal jaundice management MARKET: BY end user, 2020

FIGURE 29 Asia-Pacific neonatal jaundice management MARKET: BY end user, 2021-2028 (USD Million)

FIGURE 30 Asia-Pacific neonatal jaundice management MARKET: BY end user, CAGR (2021-2028)

FIGURE 31 Asia-Pacific neonatal jaundice management MARKET: BY end user, LIFELINE CURVE

FIGURE 32 Asia-Pacific neonatal jaundice management MARKET: BY distribution channel, 2020

FIGURE 33 Asia-Pacific neonatal jaundice management MARKET: BY distribution channel, 2021-2028 (USD Million)

FIGURE 34 Asia-Pacific neonatal jaundice management MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 35 Asia-Pacific neonatal jaundice management MARKET: BY distribution channel, LIFELINE CURVE

FIGURE 36 Asia-Pacific NEONATAL JAUNDICE MANAGEMENT market: SNAPSHOT (2020)

FIGURE 37 Asia-Pacific NEONATAL JAUNDICE MANAGEMENT market: BY COUNTRY (2020)

FIGURE 38 Asia-Pacific NEONATAL JAUNDICE MANAGEMENT market: BY COUNTRY (2021 & 2028)

FIGURE 39 Asia-Pacific NEONATAL JAUNDICE MANAGEMENT market: BY COUNTRY (2020 & 2028)

FIGURE 40 Asia-Pacific NEONATAL JAUNDICE MANAGEMENT market: BY management (2021-2028)

FIGURE 41 ASIA-PACIFIC Neonatal Jaundice Management Market: company share 2020 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Browse Related Pages

Banner